MAPT and Alzheimer disease: Initial characterization of the cases used in the IP study show that the AD cases exhibited both amyloid monomer (~ 4 kDa) and dimer (~ 8 kDa) bands along with extensive phosphorylated tau as seen with 4G8/6E10 and PHF1 specific antibodies, respectively (Fig. 4d).